Patterns of methylphenidate use and assessment of its abuse and diversion in two French administrative areas using a proxy of deviant behaviour determined from a reimbursement database: main trends from 2005 to 2008

E. FRAUGER ; V. PAULY ; F. NATALI ; V. PRADEL ; P. REGGIO ; H. COUDERT ; X. THIRION ; J. MICALLEF | 2011
Dans CNS Drugs (Vol.25, n°5, May 2011) Article : Périodique

BACKGROUND: Methylphenidate is a psychostimulant drug indicated for the treatment of attention-deficit hyperactivity disorder (ADHD). Its abuse and diversion have been previously described in specific populations, such as students; however, few [...]

Plus d'info

Ajouter à la sélection

Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling High Dosage Buprenorphine abuse

V. PAULY ; E. FRAUGER ; V. PRADEL ; F. ROUBY ; J. BERBIS ; F. NATALI ; P. REGGIO ; H. COUDERT ; J. MICALLEF ; X. THIRION | 2011
Dans Drug and Alcohol Dependence (Vol.113, n°1, January 2011) Article : Périodique

Background: Two methods have been recently developed from a drug reimbursement database to provide useful indicators for public health authorities concerning the abuse potential of psychotropic drugs. The doctor-shopping indicator (DSI) measures[...]

Plus d'info

Ajouter à la sélection